Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranscription factor binding

TRIB2 BCAS3 PCLO APBB1 GBX2 TEAD3 BCOR RUNX3 ARID1A KLF4 TBX18 CCNT2 SALL1 BAZ2A NCOA7

6.16e-0575312315GO:0008134
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

TRIB2 BCAS3 APBB1 GBX2 TEAD3 BCOR ARID1A KLF4 TBX18 SALL1 BAZ2A NCOA7

2.55e-0458212312GO:0140297
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

TRIB2 BCAS3 GBX2 TEAD3 ARID1A KLF4 TBX18 SALL1 BAZ2A NCOA7

2.61e-0441712310GO:0061629
GeneOntologyBiologicalProcessregulation of cell adhesion

DDR1 PIEZO1 DAB2 AMBRA1 RREB1 RUNX3 ARID1A KLF4 CBLB WNK1 JAK3 TBX18 LMO7 TLN1 LIMCH1 CDH1 IL7R

2.35e-0592711917GO:0030155
GeneOntologyBiologicalProcessregulation of plasma membrane bounded cell projection organization

TNIK MAG VIL1 DDR1 MYCBP2 DAB2 APBB1 CUL7 RREB1 KLF4 STK11 PPP2R5D AP2A1 CSPG4 SYNE2 CDH1

2.88e-0584611916GO:0120035
GeneOntologyBiologicalProcessregulation of cell projection organization

TNIK MAG VIL1 DDR1 MYCBP2 DAB2 APBB1 CUL7 RREB1 KLF4 STK11 PPP2R5D AP2A1 CSPG4 SYNE2 CDH1

3.66e-0586311916GO:0031344
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

FOXM1 BCAS3 DAB2 APBB1 GBX2 SUPT20HL2 ZNF395 TEAD3 RREB1 KLF4 JAK3 CCNT2 KMT2C TSC22D1 PPP2R5D SALL1 MTF1 LMO7 TOX3 NCOA7 NPAS4

4.28e-05139011921GO:0045944
GeneOntologyBiologicalProcesscell-cell adhesion

MAG SCARF2 PIEZO1 AMBRA1 PCDHA5 RUNX3 ARID1A KLF4 CBLB WNK1 JAK3 TBX18 LRFN4 ZFP36L1 TLN1 LPP CDH1 IL7R

4.49e-05107711918GO:0098609
GeneOntologyBiologicalProcesscell morphogenesis

TNIK MAG VIL1 DDR1 MYCBP2 DAB2 APBB1 GBX2 CUL7 PAK6 RREB1 RUNX3 FMNL3 ENAM STK11 NBEAL2 PTPRQ CDH1 IL7R

5.23e-05119411919GO:0000902
GeneOntologyBiologicalProcessregulation of neuron projection development

TNIK MAG DDR1 MYCBP2 DAB2 APBB1 CUL7 KLF4 STK11 PPP2R5D AP2A1 CSPG4 CDH1

5.34e-0561211913GO:0010975
GeneOntologyBiologicalProcesscirculatory system development

FOXM1 STARD13 ANKS6 CAD ACACB BCAS3 DUSP6 GBX2 CUL7 BCOR ARID1A KLF4 WNK1 AXIN2 EPN2 FMNL3 TBX18 STK11 SALL1 ZFP36L1 CSPG4

7.26e-05144211921GO:0072359
GeneOntologyBiologicalProcesscytoplasmic actin-based contraction involved in cell motility

VIL1 LIMCH1

9.86e-0531192GO:0060327
GeneOntologyBiologicalProcessregulation of protein modification process

POMT2 TNIK TRIB2 AMER1 MYCBP2 NEK10 DUSP6 DAB2 AMBRA1 CBLB WNK1 AXIN2 CCNT2 STK11 PPP2R5D CSPG4 PTPRQ NCOA7 INAVA LIMCH1 CDC25A

1.13e-04148811921GO:0031399
GeneOntologyBiologicalProcesscellular response to epidermal growth factor stimulus

VIL1 CAD DAB2 ZFP36L1

1.83e-04491194GO:0071364
GeneOntologyCellularComponentlamellipodium membrane

PIEZO1 CSPG4 SYNE2

2.75e-04221223GO:0031258
GeneOntologyCellularComponentlamellipodium

VIL1 PIEZO1 APBB1 PLEKHG5 CSPG4 SYNE2 CDH1

4.09e-042301227GO:0030027
GeneOntologyCellularComponentapical plasma membrane

TNIK ABCC1 MGAM DAB2 SHANK2 AP2A1 LMO7 CSPG4 PTPRQ USH2A

5.78e-0448712210GO:0016324
GeneOntologyCellularComponentapical part of cell

TNIK ABCC1 MGAM DAB2 SHANK2 AP2A1 LMO7 CSPG4 PTPRQ CDH1 USH2A

7.04e-0459212211GO:0045177
GeneOntologyCellularComponentcell leading edge

VIL1 BCAS3 PIEZO1 APBB1 PLEKHG5 TLN1 CSPG4 SYNE2 CDH1 USH2A

7.07e-0450012210GO:0031252
DomainAT_hook

AHCTF1 PRR12 KMT2C BAZ2A

2.87e-06161214PF02178
DomainAT_hook

AHCTF1 PRR12 KMT2C BAZ2A

2.62e-05271214SM00384
DomainAT_hook_DNA-bd_motif

AHCTF1 PRR12 KMT2C BAZ2A

2.62e-05271214IPR017956
DomainDUF4757

LMO7 LIMCH1

4.16e-0521212PF15949
DomainDUF4757

LMO7 LIMCH1

4.16e-0521212IPR031865
DomainHMGI/Y_DNA-bd_CS

AHCTF1 PRR12 KMT2C BAZ2A

4.61e-05311214IPR000637
DomainARM-type_fold

NEK10 CUL7 ARID1A FMNL3 PPP2R5D HEATR6 AP2A1 NBEAL2 NUP188

3.66e-043391219IPR016024
DomainWHEP_TRS_1

EPRS1 GARS1

4.11e-0451212PS00762
DomainWHEP-TRS

EPRS1 GARS1

4.11e-0451212SM00991
DomainWHEP-TRS

EPRS1 GARS1

4.11e-0451212PF00458
DomainWHEP-TRS_dom

EPRS1 GARS1

4.11e-0451212IPR000738
DomainWHEP_TRS_2

EPRS1 GARS1

4.11e-0451212PS51185
DomainCPSASE_1

CAD ACACB

4.11e-0451212PS00866
DomainCPSASE_2

CAD ACACB

6.14e-0461212PS00867
Domain-

EPRS1 GARS1

6.14e-04612121.10.287.10
DomainAPC_su10/DOC_dom

MYCBP2 CUL7

8.56e-0471212IPR004939
DomainDOC

MYCBP2 CUL7

8.56e-0471212PS51284
DomainCbamoylP_synth_lsu-like_ATP-bd

CAD ACACB

8.56e-0471212IPR005479
DomainBC-like_N

CAD ACACB

8.56e-0471212IPR005481
DomainANAPC10

MYCBP2 CUL7

8.56e-0471212PF03256
DomainCPSase_L_D2

CAD ACACB

8.56e-0471212PF02786
DomainBiotin_carb_N

CAD ACACB

8.56e-0471212PF00289
DomainAPC10

MYCBP2 CUL7

8.56e-0471212SM01337
DomainS15_NS1_RNA-bd

EPRS1 GARS1

1.14e-0381212IPR009068
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ANKS6 LZTR1 MYCBP2 BCAS3 PIEZO1 AMBRA1 GBX2 ZNF395 ARID1A KLF4 WNK1 PLEKHG5 MADD JAK3 PRR12 KMT2C SHANK2 AP2A1 TMEM259 NBEAL2 TLN1 CSPG4 ANKRD34A NUP188 MBD5

1.41e-1311051242535748872
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

AMER1 MYCBP2 BCAS3 STXBP4 COBLL1 APBB1 PAK6 WNK1 MADD EPN2 ZFP36L1 LMO7 SYNE2 LPP NCOA7 LIMCH1 DOP1B KIF1C

1.80e-098611241836931259
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

FOXM1 LZTR1 AHCTF1 GBX2 RUNX3 ARID1A KLF4 ZDHHC20 TSC22D1 SALL1 ZFP36L1 MTF1 BAZ2A LPP TOX3 ACIN1 DOP1B

4.82e-098081241720412781
Pubmed

A protein interaction landscape of breast cancer.

ABCC1 GARS1 DAB2 CUL7 ARID1A STK11 HEATR6 AP2A1 TLN1 LPP ACIN1 NUP188 CDH1 JPT2

6.70e-086341241434591612
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

EPRS1 CAD MYCBP2 AHCTF1 APBB1 BCOR ARID1A KMT2C BAZ2A LMO7 TLN1 LPP ACIN1

9.13e-085491241338280479
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

AMER1 ACACB STXBP4 CUL7 TEAD3 ARID1A WNK1 PPP2R5D AP2A1 LMO7 KIF1C

6.29e-074461241124255178
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

STARD13 VIL1 EPRS1 AMER1 ACACB PCLO GARS1 TEX14 ARID1A KLF4 STK11 SHANK2 AP2A1 LMO7 CSPG4 SYNE2 ACIN1 LIMCH1 CDH1

8.79e-0714421241935575683
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

TNIK MAG ABCC1 ANKS6 LZTR1 SCARF2 APBB1 PAK6 EPN2 ZDHHC20 NBEAL2 CSPG4

9.90e-075691241230639242
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

TNIK EPRS1 ACACB STXBP4 AHCTF1 APBB1 BCOR WNK1 BAZ2A TLN1 LPP ACIN1 NCOA7 PRR14L JPT2

1.28e-069341241533916271
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

TNIK MYCBP2 WNK1 KMT2C LMO7 TLN1 SYNE2 DOP1B

1.57e-06225124812168954
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ACACB TSPOAP1 DAB2 TEX14 WNK1 ZNF469 SALL1 TLN1 SYT14 INAVA

3.50e-064301241035044719
Pubmed

A census of human transcription factors: function, expression and evolution.

FOXM1 AHCTF1 GBX2 ZNF395 TEAD3 RREB1 RUNX3 KLF4 TBX18 TSC22D1 SALL1 ZFP36L1 MTF1 TOX3

4.72e-069081241419274049
Pubmed

Common genetic variants associated with breast cancer and mammographic density measures that predict disease.

NEK10 STXBP4 TOX3

5.21e-0610124320145138
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

COBLL1 PAK6 EPN2 SHANK2 LMO7 TLN1 LPP INAVA LIMCH1 CDH1 JPT2

6.11e-065651241125468996
Pubmed

The transcription factor Gbx2 induces expression of Kruppel-like factor 4 to maintain and induce naïve pluripotency of embryonic stem cells.

GBX2 KLF4

1.26e-052124228848051
Pubmed

CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities.

DDR1 CDH1

1.26e-052124230890477
Pubmed

AXIN2 and CDH1 polymorphisms, tooth agenesis, and oral clefts.

AXIN2 CDH1

1.26e-052124218683894
Pubmed

Mouse germ cell clusters form by aggregation as well as clonal divisions.

TEX14 CDH1

1.26e-052124222245112
Pubmed

ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.

ARID1A CDH1

1.26e-052124234424445
Pubmed

An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation.

SALL1 CDH1

1.26e-052124224292671
Pubmed

Novel interactions between FOXM1 and CDC25A regulate the cell cycle.

FOXM1 CDC25A

1.26e-052124223240008
Pubmed

Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice.

VIL1 KLF4

1.26e-052124222155367
Pubmed

Proper E-cadherin membrane location in colon requires Dab2 and it modifies by inflammation and cancer.

DAB2 CDH1

1.26e-052124232617970
Pubmed

DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.

DDR1 CDH1

1.26e-052124221289093
Pubmed

Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.

KLF4 CDH1

1.26e-052124220356845
Pubmed

Two novel genes TOX3 and COL21A1 in large extended Malay families with nonsyndromic cleft lip and/or palate.

COL21A1 TOX3

1.26e-052124230924295
Pubmed

Defective lymphoid development in mice lacking Jak3.

JAK3 IL7R

1.26e-05212427481769
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

EPRS1 CAD AHCTF1 COBLL1 DAB2 WNK1 LMO7 ACIN1 JPT2 KIF1C

1.37e-055031241016964243
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

EPRS1 ABCC1 AHCTF1 ZNF395 TEAD3 RREB1 BCOR ARID1A KLF4 PRR12 KMT2C AP2A1 BAZ2A LMO7 ACIN1 NUP188

1.53e-0512941241630804502
Pubmed

Diversification of Cell Lineages in Ureter Development.

AXIN2 TBX18 CDH1

1.56e-0514124328028137
Pubmed

Pbx1-dependent control of VMC differentiation kinetics underlies gross renal vascular patterning.

VIL1 CSPG4 CDH1

1.95e-0515124326138478
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

STARD13 ANKS6 AMER1 MYCBP2 COBLL1 GARS1 AMBRA1 RREB1 WNK1 EPN2 PPP2R5D AP2A1 LMO7 PTPRQ ANKRD34A KIF1C

1.97e-0513211241627173435
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

ABCC1 CAD LZTR1 MYCBP2 STXBP4 DUSP6 CUL7 BCOR ARID1A MADD PPP2R5D SYNE2 LPP CDC25A

2.37e-0510491241427880917
Pubmed

Activated Hedgehog-GLI Signaling Causes Congenital Ureteropelvic Junction Obstruction.

TBX18 SALL1 CDH1

2.39e-0516124329109083
Pubmed

Wnt3a/beta-catenin signaling controls posterior body development by coordinating mesoderm formation and segmentation.

DUSP6 AXIN2 TBX18

2.90e-0517124318045842
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

EPRS1 AMER1 STXBP4 AHCTF1 BCOR KLF4 WNK1 MADD STK11 KMT2C LPP ACIN1 NUP188 CDH1

3.39e-0510841241411544199
Pubmed

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

BCAS3 APBB1 RREB1 LMO7 SYNE2 NCOA7 KIF1C

3.45e-05251124729778605
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

MYCBP2 BCAS3 PCLO MADD EPN2 SHANK2 AP2A1 JPH3

3.65e-05347124817114649
Pubmed

A study of RUNX3, E-cadherin and β-catenin in CagA-positive Helicobacter pylori associated chronic gastritis in Saudi patients.

RUNX3 CDH1

3.77e-053124225967717
Pubmed

IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells.

JAK3 IL7R

3.77e-053124220190194
Pubmed

Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression.

KLF4 CDH1

3.77e-053124223376074
Pubmed

LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.

LMO7 LIMCH1

3.77e-053124230429017
Pubmed

Regulation of Krüppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-beta signaling.

KLF4 CDH1

3.77e-053124221177849
Pubmed

Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin.

VIL1 JAK3

3.77e-053124217537734
Pubmed

Cell biology of IL-7, a key lymphotrophin.

JAK3 IL7R

3.77e-053124215996891
Pubmed

Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration.

MAG CSPG4

3.77e-053124210366628
Pubmed

ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression.

ARID1A CDH1

3.77e-053124236420658
Pubmed

Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.

KLF4 CDH1

3.77e-053124225879941
Pubmed

Methylation of tumour suppressor genes RUNX3, RASSF1A and E-Cadherin in HCV-related liver cirrhosis and hepatocellular carcinoma.

RUNX3 CDH1

3.77e-053124231790342
Pubmed

TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.

ABCC1 TRIB2

3.77e-053124229436678
Pubmed

[Allelic imbalance of loci 17p13.1 (TP53), 1p36.1 (RUNX3), 16p22 (CDH1) and microsatellite instability in gastric cancer].

RUNX3 CDH1

3.77e-053124225509356
Pubmed

A profound deficiency in thymic progenitor cells in mice lacking Jak3.

JAK3 IL7R

3.77e-053124211034372
Pubmed

Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion.

POMT2 CDH1

3.77e-053124224297939
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

EPRS1 CAD AMER1 GARS1 TEAD3 ARID1A AXIN2 CCNT2 AP2A1 LMO7 TLN1 ACIN1 INAVA LIMCH1 CDH1

3.95e-0512471241527684187
Pubmed

Interaction network of human early embryonic transcription factors.

ACACB RREB1 BCOR ARID1A PRR12 KMT2C SALL1 CDH1

3.96e-05351124838297188
Pubmed

ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation.

AXIN2 TBX18 CDH1

4.11e-0519124326116176
Pubmed

Impaired stria vascularis integrity upon loss of E-cadherin in basal cells.

AXIN2 TBX18 CDH1

4.82e-0520124321925491
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

FOXM1 CAD STXBP4 CUL7 BCOR ARID1A WNK1 SALL1 LMO7 CIAO1

5.14e-055881241038580884
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

EPRS1 CAD GARS1 CILP2 LMO7 TLN1 ACIN1 LIMCH1 KIF1C

5.61e-05477124931300519
Pubmed

A human MAP kinase interactome.

COBLL1 DAB2 PAK6 CBLB WNK1 MADD KMT2C TSC22D1 MBD5

6.48e-05486124920936779
Pubmed

Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development.

AXIN2 TBX18 SALL1

7.44e-0523124320159597
Pubmed

Cancer gene mutation frequencies for the U.S. population.

ARID1A KMT2C

7.53e-054124234645806
Pubmed

An economical and practical method for whole-mount in situ hybridization for mouse embryos and organs.

TBX18 CDH1

7.53e-054124223088431
Pubmed

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.

ARID1A CDH1

7.53e-054124226334097
Pubmed

The prognostic impact of hypermethylation for a panel of tumor suppressor genes and cell of origin subtype on diffuse large B-cell lymphoma.

RUNX3 CDH1

7.53e-054124231093876
Pubmed

DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation.

DDR1 CDH1

7.53e-054124220432435
Pubmed

Protein tyrosine phosphatase σ targets apical junction complex proteins in the intestine and regulates epithelial permeability.

VIL1 CDH1

7.53e-054124224385580
Pubmed

Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells.

EPN2 AP2A1

7.53e-054124210336464
Pubmed

Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.

AMER1 AXIN2

7.53e-054124224251807
Pubmed

Disabled-2 is an epithelial surface positioning gene.

DAB2 CDH1

7.53e-054124217339320
Pubmed

The role of E-cadherin and Runx3 in Helicobacter Pylori - Associated gastric carcinoma is achieved through regulating P21waf and P27 expression.

RUNX3 CDH1

7.53e-054124230553475
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

PCLO RREB1 BCOR ARID1A PRR12 KMT2C SALL1 SYNE2

9.51e-05398124835016035
Pubmed

Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.

VIL1 RUNX3 CDH1

9.61e-0525124334391772
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FOXM1 EPRS1 MYCBP2 DAB2 RREB1 BCOR CCNT2 BAZ2A LMO7 ACIN1 LIMCH1

1.07e-047741241115302935
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

TNIK TSPOAP1 MADD BAZ2A TLN1 ACIN1 LIMCH1 DOP1B

1.11e-04407124812693553
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

CAD MYCBP2 AHCTF1 CUL7 ARID1A BAZ2A TLN1 SYNE2 ACIN1 NUP188

1.22e-046531241022586326
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PIEZO1 AMBRA1 BCOR PLEKHG5 FMNL3 KMT2C LMO7 NBEAL2 NUP188

1.23e-04529124914621295
Pubmed

Stat5a/b are essential for normal lymphoid development and differentiation.

JAK3 IL7R

1.25e-045124216418296
Pubmed

Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.

JAK3 IL7R

1.25e-04512429858510
Pubmed

Direct interaction between Kit and the interleukin-7 receptor.

JAK3 IL7R

1.25e-045124217554063
Pubmed

Tissue-specific roles of Axin2 in the inhibition and activation of Wnt signaling in the mouse embryo.

AXIN2 CDH1

1.25e-045124221555575
Pubmed

Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis.

AXIN2 CDH1

1.25e-045124224045232
Pubmed

Loss of Sox9 in the periotic mesenchyme affects mesenchymal expansion and differentiation, and epithelial morphogenesis during cochlea development in the mouse.

AXIN2 TBX18 CDH1

1.36e-0428124320346939
Pubmed

The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.

BCAS3 COBLL1 DAB2 WNK1 HEATR6 AP2A1

1.83e-04230124635449600
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

TNIK SCARF2 DAB2 PCDHA5 CUL7 SHANK2 BAZ2A

1.86e-04329124717474147
Pubmed

Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium.

AP2A1 CDH1

1.87e-046124222713487
Pubmed

Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus.

RUNX3 IL7R

1.87e-046124223109710
Pubmed

Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.

MAG CSPG4

1.87e-046124225866077
Pubmed

Intronic delay is essential for oscillatory expression in the segmentation clock.

AXIN2 TBX18

1.87e-046124221300886
Pubmed

Pancreatic pericytes originate from the embryonic pancreatic mesenchyme.

CSPG4 CDH1

1.87e-046124230771302
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

EPRS1 AMER1 AMBRA1 ZNF395 BCOR CDC25A

1.91e-04232124625515538
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

TNIK EPRS1 CAD ACACB MYCBP2 TSPOAP1 BCAS3 PCLO APBB1 MADD PPP2R5D SHANK2 JPH3

2.22e-0411391241336417873
Pubmed

Cdx2 regulates endo-lysosomal function and epithelial cell polarity.

VIL1 STK11 CDH1

2.23e-0433124320551175
Pubmed

Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon.

FOXM1 KLF4 CDH1

2.23e-0433124316618389
Pubmed

Canonical Wnt signaling regulates the proliferative expansion and differentiation of fibrocytes in the murine inner ear.

AXIN2 TBX18 CDH1

2.23e-0433124324727668
Pubmed

WW domains provide a platform for the assembly of multiprotein networks.

EPRS1 CAD APBB1 ARID1A AP2A1

2.35e-04154124516055720
Pubmed

Disruption of Hox9,10,11 function results in cellular level lineage infidelity in the kidney.

VIL1 CDH1

2.62e-047124229679048
Pubmed

Essential role of CR6-interacting factor 1 (Crif1) in E74-like factor 3 (ELF3)-mediated intestinal development.

VIL1 CDH1

2.62e-047124219801644
Pubmed

An Indispensable Role of Androgen Receptor in Wnt Responsive Cells During Prostate Development, Maturation, and Regeneration.

AXIN2 CDH1

2.62e-047124229451339
Pubmed

Beta-catenin and estrogen signaling collaborate to drive cyclin D1 expression in developing mouse prostate.

AXIN2 CDH1

2.62e-047124227918915
InteractionTOP3B interactions

EPRS1 ANKS6 CAD LZTR1 MYCBP2 BCAS3 PIEZO1 AMBRA1 GBX2 ZNF395 ARID1A KLF4 WNK1 PLEKHG5 MADD AXIN2 JAK3 PRR12 KMT2C SHANK2 AP2A1 TMEM259 CIAO1 NBEAL2 TLN1 CSPG4 ANKRD34A ACIN1 NUP188 MBD5 ADAMTSL4

4.40e-10147012131int:TOP3B
InteractionYWHAH interactions

AMER1 MYCBP2 BCAS3 STXBP4 COBLL1 APBB1 ZNF395 PAK6 WNK1 PLEKHG5 MADD EPN2 IFIH1 ZFP36L1 LMO7 SYNE2 LPP NCOA7 LIMCH1 CDC25A DOP1B KIF1C

5.98e-07110212122int:YWHAH
InteractionYWHAG interactions

CAD AMER1 MYCBP2 BCAS3 STXBP4 COBLL1 APBB1 ZNF395 CUL7 PAK6 WNK1 PLEKHG5 EPN2 STK11 LRFN4 ZFP36L1 LMO7 SYNE2 ANKRD34A ACIN1 CDC25A IL7R KIF1C

1.27e-06124812123int:YWHAG
InteractionSOX7 interactions

RREB1 BCOR ARID1A PRR12 KMT2C SALL1

9.98e-06821216int:SOX7
InteractionYWHAZ interactions

CAD MYCBP2 COBLL1 ZNF395 CUL7 PAK6 BCOR ARID1A WNK1 PLEKHG5 MADD EPN2 ZFP36L1 LMO7 NBEAL2 SYNE2 ANKRD34A PRR14L CDC25A CDH1 KIF1C

3.60e-05131912121int:YWHAZ
GeneFamilyFibronectin type III domain containing

TSPOAP1 LRFN4 PTPRQ USH2A IL7R

7.18e-04160805555
GeneFamilyZinc fingers CXXC-type|Methyl-CpG binding domain containing

BAZ2A MBD5

1.04e-03118021025
CoexpressionLAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE

STARD13 BCAS3 COBLL1 WNK1 KMT2C TOX3 LIMCH1

1.76e-051711247M39234
CoexpressionLAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS

STARD13 CBLB WNK1 TSC22D1 ZFP36L1 LMO7 LPP

2.20e-051771247M39245
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HPERIC

STARD13 PIEZO1 COBLL1 RUNX3 AXIN2 FMNL3 TBX18 ZFP36L1 GUCY1A1 COL21A1 TLN1 CSPG4 LPP NCOA7

2.48e-0579512414M39050
CoexpressionGSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN

ACACB APBB1 MADD AXIN2 KMT2C TSC22D1 SYNE2

4.51e-051981247M8624
CoexpressionGSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN

FOXM1 REXO5 PIEZO1 DAB2 ZNF395 SEZ6L2 CDC25A

4.65e-051991247M8031
CoexpressionGSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP

ABCC1 AHCTF1 CBLB PGAP6 MTF1 SYNE2 IL7R

4.65e-051991247M8748
CoexpressionLAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX

STARD13 BCAS3 COBLL1 TOX3 LIMCH1 MBD5

5.78e-051411246M39235
CoexpressionLAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE

BCAS3 COBLL1 CBLB WNK1 TOX3 LIMCH1 MBD5

6.15e-052081247M39233
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TNIK MGAM NEK10 BCAS3 SHANK2 COL21A1 NBEAL2 TOX3 CDH1

3.22e-0919112393e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TNIK MGAM NEK10 BCAS3 PIEZO1 SHANK2 NBEAL2 TOX3 CDH1

3.69e-09194123904bfc555743f7d8821439d05ae442d15e9886c59
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TNIK MGAM NEK10 BCAS3 PIEZO1 SHANK2 NBEAL2 TOX3 CDH1

3.69e-09194123969bff17df4a760ccf081cf52ff04af02c14f448d
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

STARD13 BCAS3 AMBRA1 KMT2C SHANK2 LPP LIMCH1 MBD5

8.48e-08199123894b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCellrenal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 ACACB NEK10 RREB1 LMO7 LPP MBD5

1.01e-061901237f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

NEK10 SHANK2 LMO7 SYNE2 TOX3 INAVA LIMCH1

1.20e-061951237dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

STARD13 BCAS3 AMBRA1 SHANK2 LPP LIMCH1 MBD5

1.24e-061961237ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

SHANK2 LMO7 NBEAL2 SYNE2 PTPRQ LIMCH1 CDH1

1.33e-06198123785f424cd9bb3117c9e322031024aabb87696ce47
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

STARD13 BCAS3 AMBRA1 SHANK2 LPP LIMCH1 MBD5

1.33e-0619812371996373bdccc55aac347d349bd22f6aad6d0c668
ToppCellControl-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class

TRIB2 TEX14 WNK1 PLEKHG5 IFIH1 SYNE2 IL7R

1.33e-061981237ee71543559836fd59adc0da877b2ca538cba60cb
ToppCellmedial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DDR1 SHANK2 LMO7 NCOA7 INAVA LIMCH1 CDH1

1.37e-061991237456460c761e26ed4b1d88d9bee4d2a7c9bd9d416
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DDR1 SHANK2 LMO7 NCOA7 INAVA LIMCH1 CDH1

1.37e-0619912375263338242f95c04690d0795749ccc20b0d19f7a
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SHANK2 LMO7 NBEAL2 SYNE2 PTPRQ LIMCH1 CDH1

1.37e-061991237d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DDR1 SHANK2 LMO7 NCOA7 INAVA LIMCH1 CDH1

1.37e-061991237c11365653c69a5dfb37946231f8af05149a61a71
ToppCellmetastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass

DDR1 SEZ6L2 TSC22D1 LMO7 TOX3 LIMCH1 CDH1

1.42e-0620012375e2def2e56f21bc7295cdcf3580f5c0d16a6a494
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type.

STARD13 SCARF2 PIEZO1 COBLL1 RREB1 TBX18 CSPG4

1.42e-06200123725f4c051c2e869481f33c22ad54de97efac444ad
ToppCellTracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PCLO SHANK2 LMO7 TOX3 LIMCH1 CDH1 DOP1B

1.42e-062001237d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type.

STARD13 SCARF2 PIEZO1 COBLL1 RREB1 TBX18 CSPG4

1.42e-062001237da45a85a4667965b24ba824af871157af5b4cd19
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DDR1 PCLO MFSD6 TSC22D1 LMO7 SYNE2 CDH1

1.42e-062001237ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRSS36 SHANK2 LMO7 PTPRQ INAVA CDH1

5.75e-0616112361e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MAG NEK10 RUNX3 ZFP36L1 NCOA7 IL7R

6.17e-06163123600e791358a7eb6c3e95f87afe22153845012e4a1
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TEAD3 SHANK2 LMO7 SYNE2 INAVA LIMCH1

7.85e-061701236a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCellmild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

TNIK ABCC1 REXO5 ACACB EPN2 SYNE2

8.12e-0617112365c8198182495bda7a826e9d80aa467f4eb1094ec
ToppCellP03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DDR1 APBB1 WNK1 LMO7 LIMCH1 CDH1

9.57e-061761236f3a54038cde58326f1caed96ecca33c141bcc8b3
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SHANK2 LMO7 NBEAL2 PTPRQ LIMCH1 CDH1

9.89e-0617712369af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellControl-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRSS36 SHANK2 LMO7 PTPRQ LIMCH1 CDH1

1.02e-051781236aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COBLL1 TEX14 SHANK2 LMO7 SYNE2 CDH1

1.05e-051791236fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 SHANK2 LMO7 PTPRQ LIMCH1 CDH1

1.05e-05179123604ce3673e46606f63d9c87bcba3a64c96817d812
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 SHANK2 LMO7 PTPRQ LIMCH1 CDH1

1.12e-051811236b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TNIK NEK10 TSC22D1 GUCY1A1 SYNE2 IL7R

1.16e-051821236b86690c109cdc16844a6cd2216c1bf2bf28efd45
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 COBLL1 TOX3 NPAP1 LIMCH1 CDH1

1.19e-051831236b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 COBLL1 TOX3 NPAP1 LIMCH1 CDH1

1.19e-051831236d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 PRSS36 SHANK2 LMO7 PTPRQ CDH1

1.19e-051831236ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.23e-05184123642ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDR1 COBLL1 WNK1 TOX3 LIMCH1 CDH1

1.23e-0518412369690d4290e70f9bda889754ffb30b0af1f7cb94b
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor

SHANK2 LMO7 NBEAL2 PTPRQ LIMCH1 CDH1

1.27e-0518512361c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor

COBLL1 SHANK2 LMO7 PTPRQ LIMCH1 CDH1

1.27e-05185123632b4e68e551d435a732f253f6ad83408c759a642
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

EPRS1 MYCBP2 AHCTF1 CBLB CCNT2 DOP1B

1.27e-051851236a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCellIPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class

TNIK ABCC1 RUNX3 CBLB JAK3 SYNE2

1.27e-05185123677fbecdab10bacc005b1c7e22ca414cfecef13c1
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 PRSS36 SHANK2 LMO7 PTPRQ CDH1

1.27e-051851236c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCellfacs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIB2 COBLL1 DUSP6 GUCY1A1 CSPG4 INAVA

1.31e-051861236e2ba9f3518d87a44537a57a648df17ab98fbbb39
ToppCellfacs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIB2 COBLL1 DUSP6 GUCY1A1 CSPG4 INAVA

1.31e-051861236fda3415222f688ef5cd8de4b0b79daa2493c585f
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PCLO DUSP6 KMT2C ZFP36L1 TLN1 USH2A

1.31e-05186123623b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 SHANK2 LMO7 PTPRQ LIMCH1 CDH1

1.31e-0518612363aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

EPRS1 MYCBP2 AHCTF1 CBLB CCNT2 DOP1B

1.31e-0518612368571956890fc9894d766ba294a28e376b4aba428
ToppCellEpithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor

SHANK2 LMO7 NBEAL2 PTPRQ LIMCH1 CDH1

1.31e-05186123609d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DDR1 EPN2 ZFP36L1 CSPG4 INAVA TMEM255A

1.35e-051871236daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCellEpithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor

COBLL1 SHANK2 LMO7 TOX3 LIMCH1 CDH1

1.35e-05187123681cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDR1 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.35e-05187123658d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SHANK2 LMO7 NBEAL2 PTPRQ LIMCH1 CDH1

1.35e-051871236d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCellhuman_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ACACB NEK10 COBLL1 SHANK2 TOX3 MBD5

1.35e-051871236f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 COBLL1 TOX3 NPAP1 LIMCH1 CDH1

1.35e-0518712362d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DDR1 EPN2 ZFP36L1 CSPG4 INAVA TMEM255A

1.35e-0518712365b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor

SHANK2 LMO7 NBEAL2 PTPRQ LIMCH1 CDH1

1.35e-05187123677f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 COBLL1 TOX3 NPAP1 LIMCH1 CDH1

1.39e-051881236e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COBLL1 TSC22D1 NBEAL2 TOX3 LIMCH1 CDH1

1.43e-051891236e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

MGAM ACACB RREB1 CBLB LMO7 SYNE2

1.43e-051891236a48df46274d51e84ffb40264646de7346104efb9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TNIK TRIB2 JAK3 SYNE2 NCOA7 IL7R

1.48e-05190123691ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellIPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class

ABCC1 RUNX3 CBLB JAK3 SYNE2 IL7R

1.48e-051901236d57df208aaf7a5554899bb9107c80b443fd0cf93
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SHANK2 LMO7 NBEAL2 PTPRQ LIMCH1 CDH1

1.48e-05190123630b50d183d7649146eb1e79b47ba897355f1998a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 COBLL1 TOX3 NPAP1 LIMCH1 CDH1

1.48e-05190123611d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCellPCW_13-14|World / Celltypes from embryonic and fetal-stage human lung

TNIK CBLB GUCY1A1 COL21A1 LIMCH1 MBD5

1.48e-05190123662a3ec1ae0829602b0569cc051210551644f1d46
ToppCell(1)_Control_(PBS)|World / Stress and Cell class

DAB2 LBP KLF4 ZFP36L1 LMO7 LIMCH1

1.52e-051911236b346e13259cb2d506b923ad44b894c21a3eee4c3
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 COBLL1 DUSP6 TOX3 LIMCH1 CDH1

1.52e-05191123696b78b4e819ea6052334bfcbc7abbf35897df885
ToppCellControl-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

COBLL1 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.57e-0519212361bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TNIK RUNX3 CBLB SYNE2 NCOA7 IL7R

1.57e-051921236ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

TNIK CBLB JAK3 KMT2C SYNE2 IL7R

1.57e-05192123647646d7e4990be85072987f92bf18d52f8da752e
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TNIK RUNX3 CBLB SYNE2 NCOA7 IL7R

1.57e-05192123658a7829b411b02b422ef75e2277a868969cc23e8
ToppCellControl-Lymphoid-T|World / Disease state, Lineage and Cell class

ABCC1 RUNX3 CBLB JAK3 SYNE2 IL7R

1.57e-051921236253cf4d2cf88ad8c45b73779336180840bef054b
ToppCellIPF-Lymphoid-T|World / Disease state, Lineage and Cell class

ABCC1 RUNX3 CBLB JAK3 SYNE2 IL7R

1.57e-051921236b25ba1f3bc842c22602b2aeed3b1b5082863e4fa
ToppCellControl-Lymphoid-T|Control / Disease state, Lineage and Cell class

ABCC1 RUNX3 CBLB JAK3 SYNE2 IL7R

1.62e-051931236af928046ccd1ca874be1534aef6ca7f27d90bc46
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDR1 COBLL1 DUSP6 WNK1 TOX3 CDH1

1.62e-05193123646d5d1f8150ebbc7f1941b96ab184491e5c1210b
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ABCC1 RUNX3 CBLB JAK3 SYNE2 IL7R

1.62e-0519312369c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCellfacs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDR1 PAK6 SALL1 LMO7 INAVA CDH1

1.66e-0519412363701ca87c6dc9ccd7b4146e56371546174d26c36
ToppCellfacs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDR1 PAK6 SALL1 LMO7 INAVA CDH1

1.66e-05194123665f9bf126be26114c2c3f4c46d48318986212a92
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COBLL1 SHANK2 LMO7 NCOA7 LIMCH1 CDH1

1.66e-05194123653f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellHSPCs-Mk_prog.|World / Lineage and Cell class

TNIK GBX2 RUNX3 MADD GUCY1A1 TLN1

1.66e-0519412365049f4f102844d766eca577e809cf21f7908a9d2
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

NEK10 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.71e-051951236fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIB2 COBLL1 DUSP6 KLF4 HEATR6 ZFP36L1

1.71e-051951236d77423d0ec64b397c6d1eec181c5fc0acaa92d63
ToppCellControl-Multiplet|Control / Disease state, Lineage and Cell class

COBLL1 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.71e-051951236618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCellnormal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass

DDR1 TSC22D1 ZFP36L1 LMO7 TOX3 NCOA7

1.71e-051951236b46544ad5af04f4dbc2643637caa3d2d50d922ae
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

NEK10 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.71e-051951236eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCellControl-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class

COBLL1 SHANK2 LMO7 SYNE2 LIMCH1 CDH1

1.71e-05195123606ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COBLL1 SHANK2 LMO7 NCOA7 LIMCH1 CDH1

1.71e-0519512369406866f99555198a9be311fbd65751b70f35446
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIB2 COBLL1 DUSP6 KLF4 HEATR6 ZFP36L1

1.71e-051951236f5bf4797972185afa76638293166abd536e5472f
ToppCellfacs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDR1 APBB1 SEZ6L2 EPN2 TSC22D1 LIMCH1

1.81e-051971236a1f7eec1aca03432caa8fe817ff6d24b29d4062d
ToppCellLAM-Epithelial|LAM / Condition, Lineage and Cell class

SEZ6L2 TSC22D1 LMO7 NCOA7 LIMCH1 CDH1

1.81e-051971236e5cf07061f6d9db7f12ac17209b267373fa2270b
ToppCellASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

PIEZO1 TEAD3 LMO7 NCOA7 LIMCH1 CDH1

1.81e-051971236dc0a6dca4af6b216357b06f67203274f8b2a8bb0
ToppCellCOVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster

TRIB2 CBLB WNK1 JAK3 SYNE2 IL7R

1.81e-05197123639ee4b93625c994813044d8dd8854fba2bd99940
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

SHANK2 LMO7 SYNE2 PTPRQ LIMCH1 CDH1

1.87e-051981236b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellControl_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type

LMO7 NBEAL2 SYNE2 PTPRQ LIMCH1 CDH1

1.87e-0519812369b161285df7a4e51618f3517cfc5b8221ba55786
ToppCellSepsis-ICU-SEP-Lymphocyte-T/NK-gd_T|ICU-SEP / Disease, condition lineage and cell class

NEK10 ZNF469 SYNE2 NCOA7 TMEM255A IL7R

1.87e-051981236b40899f8f5f32420fb4574069dd7afd9e7e70d91
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TNIK RUNX3 CBLB JAK3 SYNE2 IL7R

1.87e-05198123633a3b279c9ff3b762e52d060dae062167ca2239b
ToppCell21-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class

DDR1 KLF4 TSC22D1 LMO7 NCOA7 CDH1

1.92e-0519912368eb8b086c38960200578a9fe8853ca6e894ddee4
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DDR1 LMO7 NCOA7 INAVA LIMCH1 CDH1

1.92e-051991236c1daa481f88d5281b6b5ea8ec8bb70cc0907d613
ToppCelldistal-3-Epithelial-Club|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DDR1 ZFP36L1 LMO7 TOX3 NCOA7 CDH1

1.92e-0519912361a0c3506df2438f5be40a8ea72effe5f8ebd35c4
ToppCellNS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DDR1 MYCBP2 COBLL1 TSC22D1 ZFP36L1 LPP

1.92e-05199123632bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCellASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

PIEZO1 TEAD3 LMO7 SYNE2 LIMCH1 CDH1

1.92e-05199123648cafe44951908d03f3c6f3e185e9cbb86fb5b3b
ToppCellBiopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type

DDR1 TSC22D1 LMO7 TOX3 NCOA7 CDH1

1.92e-051991236036244251d2dd39f8184b7095418c723c0524eff
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

SHANK2 LMO7 SYNE2 PTPRQ LIMCH1 CDH1

1.92e-051991236a270630626df614f8605abddb7dee7c4d74f6149
DrugPrilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A

LZTR1 BCAS3 PIEZO1 ARID1A WNK1 ZFP36L1 NBEAL2 TLN1 KIF1C

9.77e-0719412194284_DN
DrugFlorfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A

STARD13 BCAS3 COBLL1 PCLO DAB2 KLF4 BAZ2A COL21A1 KIF1C

1.06e-0619612193083_UP
DrugColistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A

POMT2 STARD13 MFSD6 CUL7 TEAD3 CBLB JAK3 LPP NUP188

1.06e-0619612192491_UP
DrugBromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; PC3; HG-U133A

EPRS1 DUSP6 APBB1 GBX2 LBP TEAD3 CCNT2 HEATR6 LPP

1.11e-0619712191925_UP
DrugThioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A

POMT2 TNIK PCLO MFSD6 DAB2 CUL7 JAK3 STK11 LIMCH1

1.16e-0619812195635_UP
DrugLobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; HL60; HG-U133A

POMT2 ABCC1 PIEZO1 AMBRA1 WNK1 PGAP6 CCNT2 BAZ2A DOP1B

1.21e-0619912191747_UP
DrugCantharidin [56-25-7]; Up 200; 20.4uM; HL60; HT_HG-U133A

TNIK ACACB TSPOAP1 TEX14 KLF4 SHANK2 GUCY1A1 BAZ2A

5.96e-0618212183075_UP
DrugWY-14643; Down 200; 100uM; PC3; HG-U133A

TNIK REXO5 AMBRA1 ARID1A SHANK2 BAZ2A TLN1 KIF1C

8.82e-061921218464_DN
Drugretinoic acid; Down 200; 1uM; PC3; HT_HG-U133A

POMT2 TRIB2 ACACB BCAS3 SEZ6L2 NBEAL2 LPP PRR14L

9.51e-0619412181211_DN
DrugDyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

SEZ6L2 MADD EPN2 IFIH1 STK11 BAZ2A TMEM259 NBEAL2

9.51e-0619412187423_DN
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A

POMT2 TRIB2 ACACB JAK3 ZFP36L1 TLN1 CDC25A DOP1B

1.06e-0519712182328_UP
DrugTetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A

MAG ACACB DUSP6 LBP RUNX3 SHANK2 LIMCH1 NUP188

1.10e-0519812184412_UP
DrugOfloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A

COBLL1 PCLO PCDHA5 LBP JAK3 BAZ2A LMO7 TLN1

1.14e-0519912182302_UP
DrugTetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A

TRIB2 ACACB DAB2 AMBRA1 WNK1 CIAO1 NPAP1 ADAMTSL4

1.14e-0519912181739_UP
Drugpyrachlostrobin

STARD13 DDR1 PIEZO1 COBLL1 DAB2 TEAD3 RREB1 KLF4 WNK1 TLN1 CSPG4 LPP ANKRD34A ADAMTSL4 KIF1C

2.67e-0581112115ctd:C513428
DrugAC1O1I4V

MGAM SHANK2

2.80e-0521212CID000516923
DrugZrO2

MGAM ARID1A SALL1 JPT2

3.50e-05351214CID000062395
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ACACB BCAS3 MFSD6 GBX2 ARID1A GUCY1A1 IL7R

4.41e-0517612171212_DN
Druglomustine; Down 200; 100uM; PC3; HT_HG-U133A

STARD13 TNIK TRIB2 ACACB AMBRA1 PAK6 GUCY1A1

5.08e-0518012177094_DN
Drugscriptaid; Down 200; 10uM; PC3; HT_HG-U133A

ACACB CUL7 ARID1A CCNT2 LRFN4 GUCY1A1 IL7R

5.45e-0518212176896_DN
Drug17-AAG; Down 200; 1uM; PC3; HT_HG-U133A

TRIB2 ACACB PAK6 TEAD3 KLF4 GUCY1A1 CDC25A

5.84e-0518412174430_DN
DrugMonensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A

AMBRA1 IFIH1 STK11 SHANK2 TMEM259 CDC25A IL7R

6.47e-0518712177402_DN
DrugAlsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A

DUSP6 SEZ6L2 PGAP6 ZFP36L1 COL21A1 CIAO1 LIMCH1

7.39e-0519112177078_UP
Drugvinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A

ABCC1 COBLL1 TEAD3 STK11 PPP2R5D ZFP36L1 IL7R

7.63e-0519212177556_UP
DrugProgesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A

TNIK ACACB AMBRA1 PAK6 ARID1A KLF4 EPN2

7.89e-0519312176646_DN
Drugpioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A

TRIB2 REXO5 ACACB BCAS3 APBB1 CUL7 ZFP36L1

8.15e-0519412176893_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

POMT2 BCAS3 BAZ2A TMEM259 CDC25A CDH1 IL7R

8.15e-0519412173747_DN
DrugIsradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A

POMT2 STARD13 LZTR1 STK11 MTF1 BAZ2A PRR14L

8.15e-0519412176347_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

TSPOAP1 DUSP6 PCDHA5 WNK1 IFIH1 MAGEC1 KIF1C

8.15e-0519412172223_UP
DrugDicyclopentadienyl magnesium

MGAM POLI

8.37e-0531212CID011984632
Drug17-AAG; Down 200; 1uM; SKMEL5; HG-U133A

DUSP6 RUNX3 KLF4 BAZ2A CIAO1 CDC25A JPT2

8.41e-051951217505_DN
DrugPrenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A

REXO5 CUL7 RUNX3 SHANK2 TMEM259 LIMCH1 CDC25A

8.41e-0519512175070_DN
DrugMeptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A

MGAM EPN2 SHANK2 ZFP36L1 BAZ2A IL7R KIF1C

8.41e-0519512172906_UP
DrugOxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A

DUSP6 DAB2 GBX2 ZNF395 CBLB LRFN4 MTF1

8.41e-0519512171903_UP
DrugApramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A

ACACB MFSD6 GBX2 BAZ2A LMO7 CDH1 DOP1B

8.41e-0519512176614_DN
DrugClomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A

TNIK AMBRA1 KLF4 CCNT2 LMO7 LPP CDH1

8.41e-0519512176648_DN
Drug0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A

PCLO DAB2 TEX14 ARID1A IFIH1 SHANK2 TMEM259

8.41e-0519512173969_UP
Drug6-mercaptopurine monohydrate; Up 200; 10uM; PC3; HG-U133A

TRIB2 WNK1 LRFN4 HEATR6 BAZ2A LPP NPAP1

8.69e-051961217667_UP
DrugGuaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A

ABCC1 MFSD6 RUNX3 ARID1A EPN2 ACIN1 CDH1

8.69e-0519612174549_DN
DrugTocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

AMBRA1 CUL7 ARID1A WNK1 STK11 LRFN4 CDC25A

8.69e-0519612173256_UP
Druggenistein; Up 200; 10uM; MCF7; HT_HG-U133A

AMBRA1 PCDHA5 CUL7 WNK1 JAK3 LPP KIF1C

8.69e-0519612175232_UP
DrugAmyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A

ABCC1 TRIB2 DUSP6 GBX2 LRFN4 BAZ2A CIAO1

8.97e-0519712171909_UP
DrugCefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A

MFSD6 TEAD3 IFIH1 CCNT2 SHANK2 GUCY1A1 CDH1

8.97e-0519712177148_UP
DrugIsoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; PC3; HT_HG-U133A

TNIK ARID1A KLF4 ZFP36L1 BAZ2A LIMCH1 NUP188

8.97e-0519712174226_UP
DrugPentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A

POMT2 ACACB TSPOAP1 TLN1 LIMCH1 CDC25A KIF1C

8.97e-0519712172305_UP
DrugMolindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A

LZTR1 PCDHA5 SHANK2 BAZ2A CSPG4 LIMCH1 KIF1C

8.97e-0519712174199_UP
DrugBetahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A

ABCC1 ACACB MFSD6 CCNT2 STK11 TMEM259 IL7R

8.97e-0519712176611_DN
DrugVancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A

POMT2 BCAS3 APBB1 PCDHA5 KLF4 ZFP36L1 CSPG4

8.97e-0519712174598_UP
Drug(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A

POMT2 COBLL1 AMBRA1 ARID1A SHANK2 COL21A1 LIMCH1

8.97e-0519712176663_DN
DrugNeomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A

ACACB AMBRA1 PAK6 PPP2R5D BAZ2A LPP PRR14L

8.97e-0519712175867_DN
DrugDeptropine citrate [2169-75-7]; Down 200; 7.6uM; PC3; HT_HG-U133A

TNIK LZTR1 ACACB PCLO PAK6 MADD BAZ2A

8.97e-0519712175118_DN
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A

PIEZO1 COBLL1 STK11 HEATR6 TLN1 CDH1 KIF1C

9.26e-0519812172088_DN
Drugestradiol, USP; Up 200; 0.01uM; PC3; HG-U133A

STARD13 ACACB PIEZO1 DUSP6 RUNX3 WNK1 BAZ2A

9.26e-051981217665_UP
DrugNimodipine [66085-59-4]; Up 200; 9.6uM; PC3; HT_HG-U133A

REXO5 CUL7 ARID1A KLF4 ZFP36L1 NBEAL2 CDC25A

9.26e-0519812176320_UP
DrugRifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A

TNIK TRIB2 ACACB COBLL1 MFSD6 TEX14 ARID1A

9.26e-0519812174126_UP
Drugrapamycin; Up 200; 0.1uM; HL60; HG-U133A

TNIK TRIB2 ACACB HEATR6 GUCY1A1 LPP IL7R

9.55e-051991217362_UP
DrugPropylthiouracil [51-52-5]; Up 200; 23.4uM; HL60; HT_HG-U133A

COBLL1 TEAD3 SHANK2 SYNE2 CDH1 JPH3 KIF1C

9.55e-0519912172476_UP
DrugMyricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A

LBP WNK1 ZFP36L1 COL21A1 NUP188 MAGEC1 KIF1C

9.85e-0520012174170_UP
DrugDeferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A

MFSD6 PCDHA5 TEX14 HEATR6 SALL1 SHANK2 LPP

9.85e-0520012173760_UP
Drugmethyllithium

SALL1 POLI JPT2

1.33e-04191213CID000142321
DrugCai2

MGAM POLI

1.67e-0441212CID000066244
DiseaseColorectal Carcinoma

ABCC1 CAD PAK6 ARID1A WNK1 AXIN2 STK11 KMT2C LMO7 NPAP1 ACIN1 CDH1 JPH3

5.95e-0670212013C0009402
Diseaselung non-small cell carcinoma (is_implicated_in)

DDR1 RUNX3 ARID1A CBLB KMT2C IL7R

2.31e-051391206DOID:3908 (is_implicated_in)
Diseaselymphocyte count

TNIK ABCC1 TRIB2 BCAS3 PIEZO1 COBLL1 ZNF395 RREB1 RUNX3 IFIH1 STK11 ZNF469 CILP2 ZFP36L1 GUCY1A1 TLN1 LPP IL7R

2.63e-05146412018EFO_0004587
Diseasehepatoblastoma (is_marker_for)

AXIN2 SALL1 CDH1

2.88e-05151203DOID:687 (is_marker_for)
Diseaseconotruncal heart malformations, parental genotype effect measurement

SLC22A25 SLC22A24

4.91e-0531202EFO_0005939, MONDO_0016581
Disease17alpha-hydroxypregnanolone glucuronide measurement

SLC22A25 SLC22A24

4.91e-0531202EFO_0800363
Diseasehemoglobin A1 measurement

ABCC1 MGAM PIEZO1 COBLL1 RREB1 MADD MTF1 SYNE2 CDH1 KIF1C

5.45e-0552012010EFO_0007629
DiseaseAdenoid Cystic Carcinoma

BCOR ARID1A KMT2C GUCY1A1 CDH1

5.66e-051001205C0010606
DiseaseStomach Carcinoma

AXIN2 STK11 CDH1

8.27e-05211203C0699791
DiseaseCarcinoma, Granular Cell

DDR1 RUNX3 ARID1A STK11 KMT2C

1.14e-041161205C0205644
DiseaseAdenocarcinoma, Tubular

DDR1 RUNX3 ARID1A STK11 KMT2C

1.14e-041161205C0205645
DiseaseAdenocarcinoma, Oxyphilic

DDR1 RUNX3 ARID1A STK11 KMT2C

1.14e-041161205C0205642
DiseaseCarcinoma, Cribriform

DDR1 RUNX3 ARID1A STK11 KMT2C

1.14e-041161205C0205643
DiseaseAdenocarcinoma, Basal Cell

DDR1 RUNX3 ARID1A STK11 KMT2C

1.14e-041161205C0205641
DiseaseAdenocarcinoma

DDR1 RUNX3 ARID1A STK11 KMT2C

1.14e-041161205C0001418
Diseasecutaneous melanoma, hair color

RREB1 ZFP36L1 LMO7 SYNE2

1.21e-04621204EFO_0000389, EFO_0003924
Diseasepsoriasis

DDR1 PAK6 RUNX3 IFIH1 GUCY1A1 SYNE2 POLI

1.31e-042731207EFO_0000676
Diseasehormone measurement, progesterone measurement

SLC22A25 SLC22A24

1.63e-0451202EFO_0004730, EFO_0007004
DiseaseKlatskin's tumor (is_implicated_in)

ARID1A KMT2C

1.63e-0451202DOID:4927 (is_implicated_in)
Diseasediabetes mellitus

MYCBP2 COBLL1 RREB1 SALL1

1.73e-04681204EFO_0000400
Diseasehair colour measurement

TNIK PIEZO1 LBP ARID1A AXIN2 ZNF469 ZFP36L1 SYNE2 TOX3 JPH3

2.14e-0461512010EFO_0007822
Diseasestomach cancer (is_implicated_in)

BCOR ARID1A KMT2C IL7R

2.16e-04721204DOID:10534 (is_implicated_in)
DiseaseBilateral Wilms Tumor

AMER1 BCOR ARID1A

2.22e-04291203C2930471
Diseasejuvenile idiopathic arthritis

GARS1 MFSD6 RUNX3 ZFP36L1

2.40e-04741204EFO_0002609
Diseasered blood cell density measurement

STARD13 VIL1 TRIB2 BCAS3 STXBP4 PIEZO1 COBLL1 RREB1 WNK1 SALL1 ZFP36L1 POLI

2.54e-0488012012EFO_0007978
DiseaseThyroid preparation use measurement

MFSD6 CBLB IFIH1 STK11 LPP IL7R

2.69e-042171206EFO_0009933
Diseaseendometrial adenocarcinoma (is_implicated_in)

ARID1A AXIN2

3.40e-0471202DOID:2870 (is_implicated_in)
DiseaseHodgkins lymphoma

PRR12 SHANK2 LPP MAGEC1

3.56e-04821204EFO_0000183
DiseaseNephroblastoma

AMER1 BCOR ARID1A

4.25e-04361203C0027708
DiseaseHbA1c measurement

TNIK ABCC1 ACACB PIEZO1 COBLL1 RREB1 PGAP6 MADD CDH1 KIF1C

4.46e-0467512010EFO_0004541
DiseaseEmbryonal Rhabdomyosarcoma

BCOR ARID1A

4.52e-0481202C0206656
Diseasepregnanediol-3-glucuronide measurement

SLC22A25 SLC22A24

4.52e-0481202EFO_0800341
DiseaseX-12844 measurement

SLC22A25 SLC22A24

5.80e-0491202EFO_0021339
Diseasetestosterone measurement

FOXM1 STARD13 VIL1 DDR1 SLC22A25 AMER1 COBLL1 RREB1 ARID1A SLC22A24 ZFP36L1 SYNE2 USH2A JPT2

6.89e-04127512014EFO_0004908
Diseaseestrogen measurement

SLC22A25 SLC22A24

7.23e-04101202EFO_0011007
DiseaseLeukemia, Myelocytic, Acute

BCOR RUNX3 CBLB KMT2C LPP

7.24e-041731205C0023467
Diseasemultiple sclerosis

TSPOAP1 RREB1 RUNX3 CBLB PLEKHG5 ZFP36L1 LPP INAVA IL7R

7.39e-045941209MONDO_0005301
Diseasecreatinine measurement

VIL1 BCAS3 DAB2 RREB1 ARID1A KLF4 CBLB CILP2 CSPG4 LPP NCOA7 MBD5

7.57e-0499512012EFO_0004518
Diseasebasophil count

ABCC1 TSPOAP1 LBP RREB1 RUNX3 ZNF469 CILP2 IL7R

8.26e-044831208EFO_0005090
Diseasefree androgen index

DDR1 SLC22A25 COBLL1 RREB1 ARID1A SLC22A24 ZNF469

8.68e-043741207EFO_0007005
Diseasehematocrit

STARD13 TRIB2 BCAS3 PIEZO1 COBLL1 RREB1 PGAP6 PRR12 SALL1 ZFP36L1 TOX3 NCOA7

8.69e-04101112012EFO_0004348
DiseaseCongenital Abnormality

KLF4 SALL1

8.81e-04111202C0000768
DiseaseIGF-1 measurement

ACACB RREB1 ARID1A PRSS36 SALL1 SYNE2 NCOA7 DOP1B

8.83e-044881208EFO_0004627
Disease11beta-hydroxyandrosterone glucuronide measurement

SLC22A25 SLC22A24

1.05e-03121202EFO_0800573
Diseasestomach carcinoma (is_implicated_in)

BCOR CBLB

1.05e-03121202DOID:5517 (is_implicated_in)
Diseasehepatocellular carcinoma (implicated_via_orthology)

FOXM1 CAD CDH1

1.05e-03491203DOID:684 (implicated_via_orthology)
Diseasehypothyroidism

RUNX3 CBLB IFIH1 MTF1 LPP IL7R

1.10e-032841206EFO_0004705
Diseasereticulocyte count

EPRS1 BCAS3 PIEZO1 COBLL1 RREB1 RUNX3 ZNF469 ZFP36L1 SYNE2 NCOA7 CDH1 KIF1C

1.15e-03104512012EFO_0007986
Diseaselymphocyte measurement

BCAS3 PIEZO1 TMEM259 IL7R

1.35e-031171204EFO_0803546
Diseasesevere combined immunodeficiency (is_implicated_in)

JAK3 IL7R

1.45e-03141202DOID:627 (is_implicated_in)
Diseasethyroid gland papillary carcinoma (is_marker_for)

RUNX3 CDH1

1.45e-03141202DOID:3969 (is_marker_for)
Diseasememory performance

TRIB2 CBLB ZFP36L1 SYNE2 LPP LRRTM4 TOX3

1.45e-034091207EFO_0004874
DiseaseMalignant neoplasm of breast

FOXM1 ABCC1 SCARF2 STXBP4 CFHR5 ARID1A WNK1 MAMDC4 SYNE2 TOX3 ANKRD34A CDH1

1.45e-03107412012C0006142
Diseasehepatocellular carcinoma (is_marker_for)

DDR1 RUNX3 ARID1A KLF4 AXIN2 CDH1

1.48e-033011206DOID:684 (is_marker_for)
Diseasepulse pressure measurement

NEK10 COBLL1 PCDHA5 RREB1 MADD FMNL3 TBX18 CILP2 GUCY1A1 MTF1 COL21A1 LPP CDC25A MBD5

1.59e-03139212014EFO_0005763
Diseaseautoimmune thyroid disease

CBLB IFIH1 LPP IL7R

1.78e-031261204EFO_0006812
Diseaseceliac disease

RUNX3 ZFP36L1 LPP INAVA

1.78e-031261204EFO_0001060
Diseasemean corpuscular hemoglobin concentration

MAG VIL1 ABCC1 STXBP4 PIEZO1 COBLL1 GARS1 GPR152 RREB1 PGAP6 ZFP36L1 CDH1

1.85e-03110512012EFO_0004528
Diseasetriglycerides to total lipids in large HDL percentage

COBLL1 ARID1A MADD

1.90e-03601203EFO_0022330
DiseaseBenign neoplasm of stomach

AXIN2 CDH1

2.14e-03171202C0153943
DiseaseNeoplasm of uncertain or unknown behavior of stomach

AXIN2 CDH1

2.14e-03171202C0496905
DiseaseCarcinoma in situ of stomach

AXIN2 CDH1

2.14e-03171202C0154060
Diseasetriacylglycerol 56:9 measurement

BCOR MAGEC1

2.14e-03171202EFO_0010436
Diseasesphingomyelin 14:0 measurement

PAK6 SYNE2

2.14e-03171202EFO_0010390
Diseaseoral squamous cell carcinoma (is_marker_for)

DDR1 AXIN2 CDH1

2.18e-03631203DOID:0050866 (is_marker_for)
Diseasebilirubin measurement

BCAS3 PIEZO1 RREB1 ARID1A PGAP6 CILP2 MTF1

2.25e-034421207EFO_0004570
Diseaseinsomnia measurement

MYCBP2 MFSD6 TEAD3 RREB1 SALL1 LRRTM4 SYT14

2.28e-034431207EFO_0007876
Diseaseautoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease

PRSS36 LPP

2.40e-03181202EFO_0003779, EFO_0004237, EFO_0006812
DiseaseOmenn Syndrome

JAK3 IL7R

2.68e-03191202C2700553
Diseasestomach cancer (is_marker_for)

FOXM1 LZTR1 RUNX3 ARID1A

2.74e-031421204DOID:10534 (is_marker_for)
Diseasechronic kidney disease

BCAS3 DAB2 RREB1 MADD LPP

2.79e-032351205EFO_0003884
DiseaseSevere Combined Immunodeficiency

JAK3 IL7R

2.97e-03201202C0085110
Diseaseandrosterone glucuronide measurement

SLC22A25 SLC22A24

2.97e-03201202EFO_0800317
Diseasemonocyte percentage of leukocytes

TSPOAP1 PIEZO1 ARID1A WNK1 MADD IFIH1 LPP MBD5 IL7R

3.05e-037311209EFO_0007989
Diseasetype 1 diabetes mellitus

RUNX3 IFIH1 ZFP36L1 LMO7 IL7R

3.16e-032421205MONDO_0005147
Diseaseobsolete_red blood cell distribution width

MAG ABCC1 BCAS3 PIEZO1 GARS1 WNK1 PLEKHG5 PRSS36 CILP2 ZFP36L1 TMEM259 SYNE2 CDH1

3.34e-03134712013EFO_0005192
Diseasepsoriasis, type 2 diabetes mellitus

COBLL1 RUNX3 IFIH1

3.58e-03751203EFO_0000676, MONDO_0005148
Diseaseserum non-albumin protein measurement

TRIB2 DAB2 RUNX3 PRSS36 STK11 ZFP36L1

3.65e-033611206EFO_0004568
DiseaseMammary Neoplasms, Experimental

DDR1 DUSP6 TSC22D1 CDH1

3.75e-031551204C0024668
DiseaseCCL11 measurement

BCAS3 LPP

3.92e-03231202EFO_0005188

Protein segments in the cluster

PeptideGeneStartEntry
PEGVASLLPPDFQSS

ACIN1

176

Q9UKV3
PGTPAILSSPEFQAS

MAMDC4

321

Q6UXC1
FSLPQTPQTDNPSEG

AKAP2

521

Q9Y2D5
TSAFPAPVPLNSGNI

CCNT2

306

O60583
AEPFSANGSPQTELP

ADAMTSL4

201

Q6UY14
FSSSDPNIRAPQLPG

CXorf49;

426

A8MYA2
ADEPPSLDPVQSFSQ

CSPG4

1296

Q6UVK1
DTQSPFQTGTPLERP

C2orf48

96

Q96LS8
SSDFPPSLTQPAPDQ

BAZ2A

401

Q9UIF9
PPTNFSSLELEPRGQ

DDR1

391

Q08345
AQPSLGPTPEEAFLS

AP2A1

691

O95782
RTLPPSSNPTGAEFD

PPP2R5D

181

Q14738
QTGATPFSNPSLAPE

AXIN2

731

Q9Y2T1
DSDSSFTQNLPELPP

AMER1

791

Q5JTC6
EGTLTFPAQSLSPEP

APBB1

336

O00213
FESVPSSGSQLPPLE

AMBRA1

606

Q9C0C7
QSHGPSDTPQPLLDF

BCAS3

766

Q9H6U6
NGLPPSSIFLSPNEA

BCOR

631

Q6W2J9
NSQIPTPTDGPSFTV

COBLL1

1051

Q53SF7
PSPGFCTSPSEIQLQ

ANKRD34A

176

Q69YU3
AATLQFTTLPAGPPD

TSPOAP1

966

O95153
SPQDRPSFSALGPQL

JAK3

1081

P52333
LIPSQEPFPASDNSG

ACACB

41

O00763
DPFSTLGPNAVLSPQ

ARID1A

2101

O14497
SDIFAPPVSEPSGQA

DAB2

456

P98082
AQSLPSDQPVGTFSP

PAK6

306

Q9NQU5
PTAPFNLADINDVSP

KLF4

181

O43474
APLLNFSPGNLSVDP

LBP

346

P18428
FSQPGTISRPTSQDP

KMT2C

2116

Q8NEZ4
PSNDLQSTPSTEFNP

MADD

461

Q8WXG6
QPTQPASELPSGRLF

LZTR1

376

Q8N653
SSPESTQSPFEGFPQ

MAGEC1

146

O60732
SSPESTQSPFEGFPQ

MAGEC1

181

O60732
EGFPQSPLQIPVSSS

MAGEC1

296

O60732
EGFPQSPLQIPVSSS

MAGEC1

436

O60732
EGFPQSPLQIPVSSS

MAGEC1

471

O60732
GEDSLSSLHFPQSPP

MAGEC1

701

O60732
SNPEPSVAFELPSRN

MAG

436

P20916
QSTFETPSPSPGFQI

LRRTM4

396

Q86VH4
NNGTTSPDPFESQPL

EPN2

481

O95208
TQRQLPADSPGTPFL

DOP1B

2256

Q9Y3R5
IPSVPSSTPEGQLYD

MGAM

1966

O43451
NLFGSPEEATPSSRP

JPT2

26

Q9H910
GVAPNLPTIPSASDF

KIAA1109

2381

Q2LD37
SDPFVDLASGQVPLP

CBLB

856

Q13191
AQLPFTTPGPFTTND

FAM90A27P

86

A6NNH2
NPPPEEISTGTQSTF

PCLO

3726

Q9Y6V0
SQGSPEPIEPNFFTA

NEK10

1086

Q6ZWH5
SPGSIFQPQLADVSP

CUL7

326

Q14999
FIPDTPELGSPQSVS

HEATR6

446

Q6AI08
GFQNPETLADIPASP

PMS2P11

81

Q13670
PTTHNGELEPSFSPN

KIF1C

416

O43896
DDSSALPSISGNFPP

LPP

76

Q93052
LPSPTSPFSSLSQDQ

LMO7

986

Q8WWI1
RPGSFTPTEPQTQLD

GPR152

321

Q8TDT2
TNSTLPPPFSLQSGI

IL7R

411

P16871
NPLGTSFPDDTAVQP

PGAP6

111

Q9HCN3
FSPSLPQGPTSTDNP

PCDHA5

771

Q9Y5H7
FNGISREPEPPSNET

MFSD6

26

Q6ZSS7
PDSPPQDFSVKQLSG

PTPRQ

896

Q9UMZ3
PIPGAFQDSALSPTQ

PRSS36

16

Q5K4E3
TFPDPLTSPLQGQLT

NPAS4

476

Q8IUM7
AFSIDSLIGSPPQPS

GBX2

21

P52951
EDLQPPSALSAPFTN

FMNL3

176

Q8IVF7
VGTPANSLEFSDPCP

C3orf20

266

Q8ND61
NPELTDLPSPSFENA

IFIH1

96

Q9BYX4
SELTSNVFPEGLPPS

COL21A1

266

Q96P44
PRGLSSNQPLPFSDE

ANKS6

476

Q68DC2
PPPSINNGDTTSFPL

CFHR5

451

Q9BXR6
PPSSTEALNDSQEFP

TMEM259

181

Q4ZIN3
TDPLGSPDVFTRSNP

MBD5

241

Q9P267
PLDLISVPFGNSSPS

FOXM1

681

Q08050
PFDGDSITPTENPNT

ENAM

1081

Q9NRM1
SEPNNEPLFSPASEV

AHCTF1

2111

Q8WYP5
GSPLSNSQPSFPVEI

DUSP6

196

Q16828
SPVILSGPPQSFSEE

POLI

316

Q9UNA4
LNGTFPNTSEPDTEP

SLC22A25

101

Q6T423
ASANSVFPSPLPNIG

SALL1

396

Q9NSC2
AVPSEFANGLSPTPV

SALL1

951

Q9NSC2
LPSQLFEPSSNLGPN

SALL1

1056

Q9NSC2
GSSSPDISFLQPLSP

INAVA

471

Q3KP66
DADLPPNTSPFTAEL

CDH1

616

P12830
STEPNLSSFLNDPNP

LIMCH1

471

Q9UPQ0
SSEPGNFIPLFTPQS

CDC25A

191

P30304
NTSGSQTRLEPPFPA

PRR14L

1936

Q5THK1
SDPPTLNGITFSIPE

ABCC1

656

P33527
TPIQGTSELNPFSDP

RUNX3

231

Q13761
SLTQTLEAPPQDFPA

USH2A

3956

O75445
PGLSTFPSPNQITLD

STARD13

521

Q9Y3M8
EYIPGQPPLSQSSDS

EPRS1

871

P07814
SAQGSSSQLPKPFDP

SYT14

241

Q8NB59
SLFTEGTLDPQAPDP

TEX14

576

Q8IWB6
NTNSDPLDPSFPVEF

POMT2

391

Q9UKY4
QNPASPLPSFDEVDS

SYNE2

6771

Q8WXH0
VFPSSPPSGLSDEPQ

TMEM255A

301

Q5JRV8
LNGTFPNTNEPDTEP

SLC22A24

101

Q8N4F4
PGQVLFVPDANSPSS

NCOA7

151

Q8NI08
PTLQFQDVTGPSFLP

RNF165

86

Q6ZSG1
PDGPSLQLPAQTFSS

MTF1

666

Q14872
PSLPPTNGSPTFFED

NBEAL2

1686

Q6ZNJ1
PITGNDLSPPVSFNL

GARS1

266

P41250
LLDQNSQTPPPSPFS

MYCBP2

2676

O75592
SPAFQPPEIANGLDT

STK11

216

Q15831
NATSSEDFPPPSLLQ

TSC22D1

51

Q15714
LSSGPDLTLQFQAPP

SEZ6L2

606

Q6UXD5
TPLAANSPGPTLDFT

SELENOV

196

P59797
SSLSLQDPPFSPPAN

PRR12

166

Q9ULL5
GPQASTLSLFSSPPE

STXBP4

131

Q6ZWJ1
DSSFILGNPATPAPV

NPAP1

911

Q9NZP6
ALSDVFSLPSQPPSG

SHANK2

1736

Q9UPX8
SSPAPLQFFLNTPEG

SUPT20HL2

631

P0C7V6
EDPNSDPQQPTFSLT

CIAO1

281

O76071
TLVNLEPAPGFSANP

CILP2

761

Q8IUL8
PVFSLCIPNGDTSPD

TRIML2

406

Q8N7C3
TLSPTSLQDFVAPGP

PLEKHG5

821

O94827
NSNLSSGPLPIFPLE

VIL1

756

P09327
PTLPDGTNNPFAFSS

ZFP36L1

241

Q07352
SPPSPQDSLSDQEGY

ZFP36L1

291

Q07352
DPNLPPRSESFSISG

TNIK

561

Q9UKE5
SGSNQPFPIKPLSES

ZDHHC20

316

Q5W0Z9
PQDPGCTNLLSLSPF

RREB1

401

Q92766
LTNQAGETFAPPRTP

TBX18

441

O95935
ASNPEFSSIPAQISP

TLN1

1576

Q9Y490
SQSFSPNLGSPSPPE

TRIB2

36

Q92519
PPPSSDFLADVVGLQ

REXO5

131

Q96IC2
SFLEPPSGLEQPSPS

SCARF2

531

Q96GP6
IGQTNPAFSDPPLEA

TEAD3

251

Q99594
PLLEGAAPQPFTTSD

ZNF395

36

Q9H8N7
ENLTSPLFGTLSPPS

NUP188

1011

Q5SRE5
LPFQALSDPLPSQGS

TOX3

86

O15405
LSDPLPSQGSEFTPQ

TOX3

91

O15405
NGTEPSSLPFLDPNA

CAD

141

P27708
PGEFLAPVANPSSTA

ZNF469

1296

Q96JG9
CTEPFPNSTNLLPTE

PIEZO1

886

Q92508
FPGPSLTQSQQPLED

WNK1

1781

Q9H4A3
PFSLLAPGQVPNESS

GUCY1A1

16

Q02108
TPSDLTPDDSPLQSF

JPH3

466

Q8WXH2
EASPAPLVLSFSGNP

LRFN4

221

Q6PJG9